Gürkan Çelebi

881 total citations
37 papers, 599 citations indexed

About

Gürkan Çelebi is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gürkan Çelebi has authored 37 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gürkan Çelebi's work include Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Lipid metabolism and disorders (3 papers). Gürkan Çelebi is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Lipid metabolism and disorders (3 papers). Gürkan Çelebi collaborates with scholars based in Türkiye, United States and Italy. Gürkan Çelebi's co-authors include Halil Genç, Teoman Doğru, Cemal Nuri Erçin, Murat Pehlivan, Erdim Sertoğlu, Alper Sönmez, Serkan Tapan, Muammer Kara, Cumhur Erteki̇n and Hüseyin Kayadibi and has published in prestigious journals such as Journal of Hepatology, Expert Systems with Applications and Physiology & Behavior.

In The Last Decade

Gürkan Çelebi

35 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gürkan Çelebi Türkiye 14 180 136 112 103 71 37 599
Anders Nilsson Sweden 15 109 0.6× 181 1.3× 55 0.5× 11 0.1× 47 0.7× 29 953
Wenli Chen China 16 102 0.6× 153 1.1× 98 0.9× 69 0.7× 62 0.9× 64 719
Erlinda L. Kirkman United States 15 139 0.8× 291 2.1× 319 2.8× 151 1.5× 104 1.5× 27 938
Anette Karlsson Sweden 11 144 0.8× 99 0.7× 160 1.4× 51 0.5× 66 0.9× 23 567
D Seidel Germany 13 87 0.5× 149 1.1× 83 0.7× 61 0.6× 31 0.4× 64 619
Toru Koyama Japan 14 72 0.4× 310 2.3× 61 0.5× 31 0.3× 122 1.7× 54 896
Grzegorz Kozera Poland 13 223 1.2× 44 0.3× 59 0.5× 42 0.4× 128 1.8× 60 606
Qiang Xiao China 11 103 0.6× 220 1.6× 109 1.0× 188 1.8× 63 0.9× 41 657
Qizhang Wang China 17 181 1.0× 135 1.0× 43 0.4× 9 0.1× 38 0.5× 65 637
Samir Henni France 13 71 0.4× 250 1.8× 82 0.7× 70 0.7× 49 0.7× 78 485

Countries citing papers authored by Gürkan Çelebi

Since Specialization
Citations

This map shows the geographic impact of Gürkan Çelebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gürkan Çelebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gürkan Çelebi more than expected).

Fields of papers citing papers by Gürkan Çelebi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gürkan Çelebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gürkan Çelebi. The network helps show where Gürkan Çelebi may publish in the future.

Co-authorship network of co-authors of Gürkan Çelebi

This figure shows the co-authorship network connecting the top 25 collaborators of Gürkan Çelebi. A scholar is included among the top collaborators of Gürkan Çelebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gürkan Çelebi. Gürkan Çelebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çelebi, Gürkan, et al.. (2024). P506 Prevalance of the osteoporosis/osteopenia and related factors in patients with inflammatory bowel disease : An observational single-center study. Journal of Crohn s and Colitis. 18(Supplement_1). i996–i996. 1 indexed citations
2.
Gündoğmuş, İbrahi̇m, Mehmet Sinan Aydın, Bülent Çelik, et al.. (2021). Is the choice of anesthesia during gastrointestinal endoscopic procedures a result of anxiety?. Arab Journal of Gastroenterology. 22(1). 56–60. 4 indexed citations
3.
Öztürk, Kadir, Ömer Kurt, Gürkan Çelebi, et al.. (2020). High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection. The Turkish Journal of Gastroenterology. 31(3). 234–238. 10 indexed citations
4.
Çelebi, Gürkan, et al.. (2020). Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?. PubMed. 83(4). 565–570. 8 indexed citations
5.
Çelebi, Gürkan, et al.. (2017). Stabilisation of discrete-time systems via Schur stability region. International Journal of Control. 91(7). 1620–1629. 6 indexed citations
6.
Genç, Halil, et al.. (2016). Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease.. PubMed. 20(20). 4305–4312. 19 indexed citations
7.
Erçin, Cemal Nuri, Teoman Doğru, Gürkan Çelebi, et al.. (2016). The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 46(4). 985–991. 8 indexed citations
8.
Kara, Muammer, Teoman Doğru, Halil Genç, et al.. (2015). Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology. 27(10). 1144–1148. 25 indexed citations
9.
Sertoğlu, Erdim, Cemal Nuri Erçin, Gürkan Çelebi, et al.. (2014). The relationship of serum uric acid with non-alcoholic fatty liver disease. Clinical Biochemistry. 47(6). 383–388. 54 indexed citations
10.
Genç, Halil, Teoman Doğru, Gürkan Çelebi, et al.. (2013). Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis. 55(2). 84–84. 5 indexed citations
11.
Genç, Halil, Teoman Doğru, Serkan Tapan, et al.. (2011). Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome. Clinical Biochemistry. 45(1-2). 92–95. 14 indexed citations
12.
Sönmez, Alper, Gürkan Çelebi, Gökhan Erdem, et al.. (2010). Plasma Apelin and ADMA Levels in Patients with Essential Hypertension. Clinical and Experimental Hypertension. 32(3). 179–183. 79 indexed citations
13.
Saraç, Fulden, et al.. (2009). Thermogenic response and leptin levels rise after recovery of the euthyroid state. Journal of Endocrinological Investigation. 33(4). 254–257. 1 indexed citations
14.
Kutlu, Mustafa, Alper Sönmez, Halil Genç, et al.. (2009). Relationship between hemoglobin and CD40 ligand in prediabetes. Clinical and investigative medicine. 32(6). E244–E250. 16 indexed citations
15.
Saraç, Fulden, et al.. (2006). Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry. Advances in Therapy. 23(6). 1016–1029. 16 indexed citations
16.
Saraç, Fulden, Murat Pehlivan, Gürkan Çelebi, et al.. (2005). Thermogenic Response in the Hyperthyroid and Hypothyroid. Biotechnology & Biotechnological Equipment. 19(2). 150–156. 1 indexed citations
17.
Taşkıran, Emin, et al.. (1997). Effect of tibial tubercle elevation on patellofemoral compressive force in patellofemoral arthrosis. Knee Surgery Sports Traumatology Arthroscopy. 5(1). 31–35. 3 indexed citations
18.
Çelebi, Gürkan, et al.. (1997). Electrodermal activity in patients with Parkinson's disease. Clinical Autonomic Research. 7(1). 35–40. 13 indexed citations
19.
Çelebi, Gürkan, et al.. (1991). Prevention of neurovascular complications in extension osteotomy of the tibia in poliomyelitis. International Orthopaedics. 15(1). 29–30.
20.
Çelebi, Gürkan, et al.. (1983). Biomechanical basis of the tibial recurvation osteotomy.. PubMed. 17(3). 77–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Nilsson Breakdown of academic impact, for papers by Wenli Chen Breakdown of academic impact, for papers by Erlinda L. Kirkman Breakdown of academic impact, for papers by Anette Karlsson Breakdown of academic impact, for papers by D Seidel Breakdown of academic impact, for papers by Toru Koyama Breakdown of academic impact, for papers by Grzegorz Kozera Breakdown of academic impact, for papers by Qiang Xiao Breakdown of academic impact, for papers by Qizhang Wang Breakdown of academic impact, for papers by Samir Henni
Rankless by CCL
2026